Phase 2 data from the ongoing HIBISCUS study shows promise that investigational etavopivat could reduce the incidence of vaso-occlusive crises in people with sickle cell disease
| ESGYX Fund | USD 21.26 0.15 0.70% |
Slightly above 62% of Mirova Global's investor base is looking to short. The analysis of overall sentiment of trading Mirova Global Sustainable mutual fund suggests that many investors are alarmed at this time. Mirova Global's investing sentiment can be driven by a variety of factors including economic data, Mirova Global's earnings reports, geopolitical events, and overall market trends.
Mirova |
Novo Nordisk today announced 52-week results from the phase 2 part of the ongoing phase 23 HIBISCUS study program of investigational etavopivat in people with sickle cell disease. These results were presented at the 66th Annual Meeting and Exposition of the American Society of Hematology in San Diego, California.
Read at finance.yahoo.com
 |
Mirova Global Fundamental Analysis
We analyze Mirova Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mirova Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mirova Global based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Mirova Global is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Mirova Global Sustainable Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mirova Global mutual fund to make a market-neutral strategy. Peer analysis of Mirova Global could also be used in its relative valuation, which is a method of valuing Mirova Global by comparing valuation metrics with similar companies.
Peers
Mirova Global Related Equities
| FNFPX | American Funds | 0.40 |
| ||
| RNPAX | New Perspective | 0.40 |
| ||
| FFPNX | American Funds | 0.40 |
| ||
| CNPCX | New Perspective | 0.41 |
| ||
| CNPAX | New Perspective | 0.63 |
| ||
| CNPFX | New Perspective | 0.63 |
| ||
| CNPEX | New Perspective | 0.64 |
| ||
| ANWPX | New Perspective | 0.64 |
| ||
| NPFCX | New Perspective | 0.64 |
| ||
| NPFFX | New Perspective | 0.64 |
|
Other Information on Investing in Mirova Mutual Fund
Mirova Global financial ratios help investors to determine whether Mirova Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mirova with respect to the benefits of owning Mirova Global security.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |